Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Torsten Wiegand (NPI 1861461402)

Field	Value
Entity Type	Individual
Organization	Torsten Wiegand
Address	50 Staniford St
City	Boston
State	MA
ZIP	02114
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	March 16, 2006

Payer Source	Total Paid
Medicare	$7.6M
Medicaid	$0

Key Findings

This provider is effectively a single‑payer Medicare practice: lifetime Medicare revenue is $7.6M and there is no Medicaid billing on file, so the provider’s entire documented public payer footprint is Medicare-driven. The dataset also reports that the top 3 Medicare codes by revenue account for 89.2% of this provider's total Medicare revenue, indicating extreme concentration in a narrow set of services.

Revenue is highly concentrated in anti‑VEGF drug administration and intravitreal procedures: J0178 accounts for $5.4M (71.6% of Medicare revenue), J2778 accounts for $872.1K (11.5%), and 67028 accounts for $465.8K (6.1%); the precomputed top‑3 share is 89.2% of Medicare revenue. This mix shows the practice’s financial exposure is overwhelmingly tied to a few high‑volume ophthalmic procedural services rather than diversified E/M or ancillary lines.

Clinical service mix and workflow likely center on high‑volume intravitreal injection and retina imaging: the practice billed 7.9K claims for J0178 (avg paid/claim $690), 4.8K claims for J2778 (avg paid/claim $181), and 6.9K claims for 92134 (6.9K claims, $34 avg paid/claim, $235.7K revenue). Procedural and imaging codes dominate activity while typical office E/M visits generate comparatively little revenue (for example, 99213 shows 327 claims and $22.9K revenue).

On national competitive standing the provider is an outlier for multiple retina/procedural codes: J0178 ranks #2 of 3204 providers nationally (100th percentile; extreme outlier, far above typical national volume) and 67028 ranks #20 of 4255 providers nationally (100th percentile; extreme outlier). These rankings indicate the provider operates at a scale for these services that is well above typical national peers for retina procedures.

The provider is also a top national performer on retina imaging and comprehensive established‑patient exams: 92134 ranks #7 of 26868 providers nationally (100th percentile; extreme outlier) and 92014 ranks #32 of 35415 providers nationally (100th percentile; extreme outlier). High rankings across both diagnostic imaging and exam codes suggest an integrated retina clinic model that couples frequent imaging with procedural treatment.

Not all billed codes are extreme outliers — several drug and ancillary codes show typical volumes: J2777 (faricimab) is reported as typical/unremarkable volume, and J9035 (bevacizumab) with 763 claims and $42K revenue is described as typical despite being at higher percentiles for some peers. This nuance shows the practice’s dominance is concentrated in a subset of agents and procedures rather than uniformly across every retina drug or ancillary service.

Operationally, the claims and average paid per claim point to a throughput, drug‑delivery focused practice: J0178 shows 7.9K claims at $690 avg paid/claim and J2778 shows 4.8K claims at $181 avg paid/claim, indicating that high utilization of a high‑priced injectable is the principal revenue engine. The combination of very high claim counts and substantial average payments for select drugs implies a procedural site optimized for frequent in‑office injections.

The provider has a long tenure in the dataset (NPI enumerated 2006-03-16 (~20 years ago)), consistent with sustained high volumes reported across multiple years; long enumeration combined with extreme national ranks for core retina codes suggests an established, procedure‑focused retina practice rather than a new entrant scaling rapidly.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

11 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	7,870	$690	$5.4M
J2778	Injection, ranibizumab, 0.1 mg	4,820	$180	$872.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	4,200	$110	$465.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	3,510	$100	$347.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	6,930	$30	$235.7K
J2777	Injection, faricimab‑svoa, 0.1 mg	4,800	$30	$139.2K
J9035	Injection, bevacizumab, 10 mg	760	$60	$42K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	330	$70	$22.9K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	160	$120	$19.1K
92201	The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece…	300	$20	$6K

Showing 1–10 of 11

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 11 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Torsten Wiegand — 5 of 11 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

11 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	90	790	$690	$826.5K
J2777	35	50	7,080	$30	$343.1K
J2778	1	30	560	$180	$200.7K
67028	3	120	570	$100	$80.7K
92014	1	1,070	160	$90	$30.1K
J9035	9	80	250	$50	$19.7K
92012	428	560	90	$70	$12.4K
92134	2	670	70	$30	$10.6K
99213	1,512	13,700	70	$60	$8.8K
92004	60	890	40	$100	$6.3K

Showing 1–10 of 11

Related Providers

Other providers that share a Tax Identification Number (TIN) with Torsten Wiegand, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The General Hospital Corporation	MA	General Acute Care Hospital	$0	$438M
Community Physicians Of Indiana Inc	IN	Family Medicine Physician	$0	$185M
Massachusetts General Physicians Organization Inc	MA	Dermatology Physician	$0	$60.2M
Boston Emergency Physician Foundation, Inc.	MA	Emergency Medicine Physician	$0	$24.3M
Colorado Permanente Medical Group, P.C.	CO	Internal Medicine Physician	$0	$23.2M
David Reed	MA	Retina Specialist (Ophthalmology) Physician	$7.7M	$0
Chirag Shah	MA	Retina Specialist (Ophthalmology) Physician	$5M	$0
Roger Goldberg	CA	Retina Specialist (Ophthalmology) Physician	$4.6M	$0
Miriam Englander-paschalis Ilios	MA	Retina Specialist (Ophthalmology) Physician	$4.5M	$0
Babak Jian Seyedahmadi	MA	Ophthalmology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Torsten Wiegand, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Massachusetts Eye And Ear Infirmary	MA	General Acute Care Hospital	$0	$68.1M
Bay Cove Human Services, Inc	MA	Community/Behavioral Health Agency	$630.5K	$36.4M
Jewish Family & Children's Service	MA	Case Management Agency	$0	$12.5M
Commonwealth Of Massachusetts	MA	Case Management Agency	$0	$10.4M
Massachusetts Eye And Ear Associates, Inc.	MA	Ophthalmology Physician	$0	$6.6M
Jeffrey Heier	MA	Retina Specialist (Ophthalmology) Physician	$3.6M	$0
Adam Chin	MA	Ophthalmology Physician	$3.4M	$870
Tina Cleary	MA	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Boston Eye Surgery & Laser Center Trust	MA	Ambulatory Surgical Clinic/Center	$2.1M	$415.8K
Marianeli Rodriguez	MA	Ophthalmology Physician	$2.4M	$0

Torsten Wiegand — Billing Profile & Reimbursement Data

Sign up for Torsten Wiegand — Billing Profile & Reimbursement Data policy alerts

Torsten Wiegand — Billing Profile & Reimbursement Data

Sign up for Torsten Wiegand — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References